MA51292A - METHODS AND APPARATUS FOR GIVING VACCINES AGAINST THE HEPATITIS B VIRUS (HBV) - Google Patents

METHODS AND APPARATUS FOR GIVING VACCINES AGAINST THE HEPATITIS B VIRUS (HBV)

Info

Publication number
MA51292A
MA51292A MA051292A MA51292A MA51292A MA 51292 A MA51292 A MA 51292A MA 051292 A MA051292 A MA 051292A MA 51292 A MA51292 A MA 51292A MA 51292 A MA51292 A MA 51292A
Authority
MA
Morocco
Prior art keywords
hbv
hepatitis
virus
giving
methods
Prior art date
Application number
MA051292A
Other languages
French (fr)
Inventor
Robert M Bernard
Daniel Boden
Thomas David Cox
Pooter Dorien De
Andrew W Hannaman
Adam Hartman
Helen Horton
Stephen A Morse
Jean-Marc Edmond Fernand Marie Neefs
Soumitra Roy
Oliver Ruck
Original Assignee
Ichor Medical Systems Inc
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichor Medical Systems Inc, Janssen Sciences Ireland Unlimited Co filed Critical Ichor Medical Systems Inc
Publication of MA51292A publication Critical patent/MA51292A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205Vaccinating by means of needles or other puncturing devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/24Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0412Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0502Skin piercing electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details
    • A61N1/306Arrangements where at least part of the apparatus is introduced into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2073Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/00034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA051292A 2017-12-19 2018-12-18 METHODS AND APPARATUS FOR GIVING VACCINES AGAINST THE HEPATITIS B VIRUS (HBV) MA51292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762607430P 2017-12-19 2017-12-19
US2017067269 2017-12-19

Publications (1)

Publication Number Publication Date
MA51292A true MA51292A (en) 2020-10-28

Family

ID=65009810

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051292A MA51292A (en) 2017-12-19 2018-12-18 METHODS AND APPARATUS FOR GIVING VACCINES AGAINST THE HEPATITIS B VIRUS (HBV)

Country Status (12)

Country Link
EP (1) EP3727441A1 (en)
JP (1) JP2021506431A (en)
KR (1) KR20200101388A (en)
CN (1) CN111867624A (en)
AU (1) AU2018390825A1 (en)
BR (1) BR112020012171A2 (en)
CA (1) CA3085492A1 (en)
IL (1) IL275429A (en)
MA (1) MA51292A (en)
MX (1) MX2020006478A (en)
SG (1) SG11202005709QA (en)
WO (1) WO2019126120A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389531B2 (en) 2017-12-19 2022-07-19 Janssen Sciences Ireland Unlimited Company Methods and apparatus for the delivery of hepatitis B virus (HBV) vaccines
EA202091513A1 (en) 2017-12-19 2020-09-09 Янссен Сайенсиз Айрлэнд Анлимитед Компани VACCINES AGAINST HEPATITIS B VIRUS (HBV) AND THEIR APPLICATION
US11020476B2 (en) 2017-12-19 2021-06-01 Janssen Sciences Ireland Unlimited Company Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
MA56535A (en) * 2019-06-20 2022-04-27 Janssen Sciences Ireland Unlimited Co SELF-REPLICATING RNA MOLECULES FOR HEPATITIS B VIRUS (HBV) VACCINES AND USES THEREOF
CN111267290B (en) * 2020-02-25 2021-09-21 南京六合科技创业投资发展有限公司 Automatic stirring and filling equipment for heat insulation material for pipeline heat insulation maintenance
WO2023233290A1 (en) 2022-05-31 2023-12-07 Janssen Sciences Ireland Unlimited Company Rnai agents targeting pd-l1

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
US6041252A (en) 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US5873549A (en) 1996-09-25 1999-02-23 Mcdonnell Douglas Corporation Vehicle rotation and control mechanism
CA2520768A1 (en) * 2003-03-28 2005-02-10 Idm Pharma, Inc. Methods of identifying optimal variants of peptide epitopes
ES2695235T3 (en) * 2004-03-08 2019-01-02 Ichor Medical Systems Inc Improved apparatus for the delivery, electrically mediated, of therapeutic agents
KR100836745B1 (en) * 2007-01-31 2008-06-10 (주)두비엘 An hbv vaccine and a process of preparing the same
CN102851313B (en) * 2008-01-28 2015-01-28 多贝尔有限公司 Hepatitis b vaccine and preparation technology thereof
KR20120052352A (en) * 2009-08-07 2012-05-23 트랜스진 에스.에이. Composition for treating hbv infection
EA037377B1 (en) * 2011-02-11 2021-03-22 Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания Vaccine for inducing an immune response against hbv
JP5745102B2 (en) * 2011-02-12 2015-07-08 グローブイミューン,インコーポレイテッド Yeast-based immunotherapy composition for chronic hepatitis B infection
TWI623618B (en) * 2011-07-12 2018-05-11 傳斯堅公司 Hbv polymerase mutants
GB201223386D0 (en) * 2012-12-24 2013-02-06 Immune Targeting Systems Its Ltd Vaccine
WO2016020538A1 (en) * 2014-08-08 2016-02-11 Transgene Sa Hbv vaccine and antibody combination therapy to treat hbv infections
AU2015323944B2 (en) * 2014-10-01 2018-11-29 Inovio Pharmaceuticals, Inc. Vaccines having an antigen and interleukin-21 as an adjuvant
EP3436139A4 (en) * 2016-03-28 2020-06-17 Ichor Medical Systems Inc. Method and apparatus for delivery of therapeutic agents

Also Published As

Publication number Publication date
EP3727441A1 (en) 2020-10-28
CN111867624A (en) 2020-10-30
SG11202005709QA (en) 2020-07-29
JP2021506431A (en) 2021-02-22
MX2020006478A (en) 2020-09-22
AU2018390825A1 (en) 2020-06-18
KR20200101388A (en) 2020-08-27
CA3085492A1 (en) 2019-06-27
BR112020012171A2 (en) 2020-11-24
WO2019126120A1 (en) 2019-06-27
IL275429A (en) 2020-08-31

Similar Documents

Publication Publication Date Title
MA51292A (en) METHODS AND APPARATUS FOR GIVING VACCINES AGAINST THE HEPATITIS B VIRUS (HBV)
MA51311A (en) HEPATITIS B VIRUS (HBV) VACCINES AND RELATED USES
HK1248681A1 (en) Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
MA50278A (en) METHODS FOR THE TREATMENT OF SUBJECTS INFECTED WITH THE HEPATITIS B VIRUS (HBV) INFECTION
MA49463A (en) HERPES SIMPLEX VACCINE
EP3439696A4 (en) Therapeutic vaccine for hepatitis b virus (hbv) using the hbv core antigen
MA46024A (en) HERPES SIMPLEX VACCINE
EP3710049A4 (en) A therapeutic vaccine for hepatitis b virus (hbv) using the hbv pres1 and/or pres2, and/or s-hbsag regions of the hbv envelope protein
IL244431A0 (en) Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection
IL249660B (en) Methods for the treatment of hepatitis b and hepatitis d virus infections
MA51312A (en) METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE AGAINST THE HEPATITIS B VIRUS (HBV)
IL290999A (en) Hbv vaccines and methods treating hbv
IL255366A0 (en) Reagents for treatment of hepatitis b virus (hbv) infection and use thereof
MA52011A (en) PEPTIDIC VACCINES AGAINST INTERLEUKIN-31
MA56535A (en) SELF-REPLICATING RNA MOLECULES FOR HEPATITIS B VIRUS (HBV) VACCINES AND USES THEREOF
EP3515929A4 (en) Hepatitis b therapeutic vaccines
IL290924A (en) Hepatitis b virus vaccines
MA56524A (en) ARENAVIRUS VECTORS FOR HEPATITIS B VIRUS (HBV) VACCINES AND USES THEREOF
MA45994A (en) VACCINES AGAINST VIRUSES
IL277128A (en) Hepatitis b vaccines and uses of the same
IL272094A (en) Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
IL271491B1 (en) Treatment of hepatocellular carcinoma characterized by hepatitis b virus infection
HK1259329A1 (en) Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus
EP3615054A4 (en) NUCLEOSIDE-MODIFIED mRNA-LIPID NANOPARTICLE LINEAGE VACCINE FOR HEPATITIS C VIRUS
EP3452595A4 (en) Reagents for treatment of hepatitis b virus (hbv) infection and use thereof